Last reviewed · How we verify
NCT06620120
Investigate the Effect of EPITACT® Light Legs Therapeutic Insoles on the Symptoms and Quality of Life of Patients With Chronic Venous Disease
NA trial testing Insoles in Venous Disease in 50 participants. Completed in 31 March 2024.
11 February 2024
Quick facts
| Lead sponsor | Millet Innovation |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 50 |
| Start date | 1 November 2023 |
| Primary completion | 11 February 2024 |
| Estimated completion | 31 March 2024 |
| Sites | 1 location across France |
Drugs / interventions tested
- Insoles
- Without insoles
Conditions studied
- Venous Disease — all drugs for Venous Disease →
- Quality of Life — all drugs for Quality of Life →
- Symptoms and Signs — all drugs for Symptoms and Signs →
Sponsor
Millet Innovation
Who can join
18 and older, any sex, with Venous Disease or Quality of Life. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The main objective is to evaluate the effect of wearing the insoles developed by Millet Innovation on the symptoms and quality of life of patients suffering from chronic venous disease.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06620120
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Insoles
Trials testing the same drug.
- NCT07234240 — Blinded Consumer Study for the Evaluation of the Usability and Efficacy of One Medical Device in Venous Return · NA · completed
- NCT05408156 — Effects of Customized Insoles for Individuals With Symptomatic Hallux Valgus · NA · not yet recruiting
- NCT06395025 — Blinded User Study for the Evaluation of the Acceptability and Efficacy of One Medical Device in Venous Return in Compar · NA · completed
- NCT06153680 — Consumer Study for the Evaluation of the Usability and Efficacy of One Medical Device in Venous Return · NA · completed
- NCT05877482 — Pediatric Pes Planus: Effect of Insoles With and Without SFE · NA · unknown
Other recruiting trials for Venous Disease
Currently open trials in the same condition.
- NCT05050799 — US Post-Market Surveillance Study of the Surfacer System · recruiting
- NCT05628948 — Vascular Lab Resource (VLR) Biorepository · recruiting
Other Millet Innovation trials
Trials by the same sponsor.
- NCT07234240 — Blinded Consumer Study for the Evaluation of the Usability and Efficacy of One Medical Device in Venous Return · NA · completed
- NCT06395025 — Blinded User Study for the Evaluation of the Acceptability and Efficacy of One Medical Device in Venous Return in Compar · NA · completed
- NCT06153680 — Consumer Study for the Evaluation of the Usability and Efficacy of One Medical Device in Venous Return · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06620120 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Millet Innovation
- Last refreshed: 1 October 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06620120.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing